Last Updated: 13 Sep 2024
Executive Summary
Masimo Corporation (MASI) is a leading provider of non-invasive monitoring technologies and hospital automation solutions. The company has a strong financial performance, with a market capitalization of over $6 billion and an EBITDA of $212.1 million. Masimo's stock price is currently trading at $113, which is below its 52-week high of $153.93. However, the stock is still above its 52-week low of $75.22. The company's fundamentals are strong, with a trailing PE ratio of 76.87 and a forward PE ratio of 40. Masimo also has a strong technical outlook, with a 50-day moving average of $114.45 and a 200-day moving average of $123.56. The company's short-term outlook is positive, with analysts expecting the stock price to rise to $155 in the next 12 months. The long-term outlook is also positive, with analysts expecting the stock price to continue to rise over the next 5 years.
Company Overview
Masimo Corporation is a global provider of non-invasive monitoring technologies and hospital automation solutions. The company's products are used in a variety of healthcare settings, including hospitals, clinics, and home healthcare. Masimo's products are designed to improve patient safety and outcomes by providing accurate and reliable monitoring data. The company's flagship product is the Masimo SET pulse oximeter, which is the most widely used pulse oximeter in the world. Masimo also offers a variety of other monitoring products, including capnography, brain function monitoring, and hemodynamic monitoring. In addition to its monitoring products, Masimo also offers a variety of hospital automation solutions, including patient monitoring systems, anesthesia delivery systems, and electronic medical records.
Fundamental Analysis
Masimo Corporation has a strong financial performance. The company's revenue has grown steadily over the past several years, and its profitability has improved. In 2023, Masimo reported revenue of $2.017 billion and net income of $212.1 million. The company's gross profit margin is 52.5%, and its operating profit margin is 5.7%. Masimo has a strong balance sheet, with $1.1 billion in cash and equivalents and no debt. The company's financial performance is expected to continue to improve in the future.
Technical Analysis
Masimo Corporation's stock price has been trending higher over the past year. The stock price is currently trading at $113, which is below its 52-week high of $153.93. However, the stock is still above its 52-week low of $75.22. The stock's technical indicators are positive, with a 50-day moving average of $114.45 and a 200-day moving average of $123.56. The stock's relative strength index (RSI) is 55, which indicates that the stock is neither overbought nor oversold.
Short Term Outlook
The short-term outlook for Masimo Corporation is positive. The stock price is trading above its 50-day and 200-day moving averages, and the RSI is in neutral territory. The company's financial performance is strong, and analysts expect the stock price to rise to $155 in the next 12 months.
Long Term Outlook
The long-term outlook for Masimo Corporation is also positive. The company is a leader in the non-invasive monitoring and hospital automation markets. The company's products are used in a variety of healthcare settings, and the demand for these products is expected to continue to grow in the future. Masimo has a strong financial foundation, and the company is well-positioned to continue to grow in the future.
Analyst Recommendations
Analysts are bullish on Masimo Corporation. The average analyst rating for the stock is "Buy," and the average analyst target price is $155. Three analysts have a "Strong Buy" rating on the stock, three analysts have a "Buy" rating, and three analysts have a "Hold" rating. No analysts have a "Sell" or "Strong Sell" rating on the stock.
